miR-17 as a diagnostic biomarker regulates cell proliferation in breast cancer

BACKGROUND: MicroRNAs (miRNAs) have been shown to be involved in the initiation and progression of cancers in the literature. In this study, we aimed to evaluate the clinicopathological role of miR-17 in breast cancer. MATERIALS AND METHODS: The expression of miR-17 was measured in 132 breast cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Fangliang, Li, Yuan, Xu, Lingyun, Zhu, Yulan, Gao, Haiyan, Zhen, Lin, Fang, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293507/
https://www.ncbi.nlm.nih.gov/pubmed/28203087
http://dx.doi.org/10.2147/OTT.S127723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293507/
https://www.ncbi.nlm.nih.gov/pubmed/28203087
http://dx.doi.org/10.2147/OTT.S127723

Ejemplares similares